Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Estimation of Glomerular Filtration Rate by Serum Cystatin C in Preventing Contrast Induced Nephropathy by N-Acetylcysteine or Zinc

NCT00399256 is registered in ClinicalTrials.gov with Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) as lead sponsor.

NCT NCT00399256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Estimation of Glomerular Filtration Rate by Serum Cystatin C in Preventing Contrast Induced Nephropathy by N-Acetylcysteine or Zinc
Lead sponsor
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2004
Completion date
March 31, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure